Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2005
06/08/2005EP1537116A1 Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
06/08/2005EP1537115A1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
06/08/2005EP1537114A1 Organic compounds as agents for the treatment of aldosterone mediated conditions
06/08/2005EP1537113A1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
06/08/2005EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity
06/08/2005EP1537104A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
06/08/2005EP1537099A1 Pyrrole based inhibitors of glycogen synthase kinase 3
06/08/2005EP1537089A2 Compounds compositions and methods
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005CN1625589A Fluorescent compositions comprising diketopyrrolopyrroles
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof
06/08/2005CN1205211C Pleuromutilin derivatives as antimicrobials
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903106 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders
06/07/2005US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903091 Kidney diseases; hypotensive agents; blood disorders
06/07/2005US6903090 Such as 10-(2-ethoxyphenyl)-1,2,3,4,5,6-hexahydroazepino(4,5-b)indole; for treatment of anxiety, depression, schizophrenia, epilepsy, migraine, Alzheimers disease, sleep disorders, obesity, stress related diseases, and/or drug withdrawal
06/07/2005US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005US6901929 Aerosolization; comprises pressurization cylinders; drug delivery
06/02/2005WO2005049617A1 Pyrazolopyrimidines
06/02/2005WO2005049616A1 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
06/02/2005WO2005049615A1 Pyrazolo`1,5-a!`1,3,5! triazin -4-one derivatives as cb1 receptor antagonists
06/02/2005WO2005049614A2 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin
06/02/2005WO2005049611A1 5-substituted imidazoles
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
06/02/2005WO2005048953A2 Amide derivatives as kinase modulators
06/02/2005WO2005048948A2 Urea derivatives as kinase modulators
06/02/2005WO2005048710A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005WO2005028480A3 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
06/02/2005WO2005023806A3 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
06/02/2005WO2005019220A9 Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
06/02/2005WO2005016878A3 METHODS FOR THE PREPARATION OF 5-FLUORO-PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
06/02/2005US20050119486 Diamine derivatives
06/02/2005US20050119453 Method of removing transition metals
06/02/2005US20050119295 Fused heterocyclic compounds
06/02/2005US20050119287 8-(1-methyl-1H-pyrrol-2-yl)-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidine-2,6-dione; asthma, chronic obstructive pulmonary disorder, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders
06/02/2005US20050119282 Pyrazolopyrimidines and related analogs as HSP90-inhibitors
06/02/2005US20050119280 1-[alkyl 1-[heteroaryl )alkyl] and 1-[ aryl) alkyl]-7-( pyrimidin-4-yl) imadazo [1,2-a] pyrimidin-5(1h)-one derivatives
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119269 Heterocyclic compounds and methods of making and using thereof
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119228 Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
06/02/2005US20050119168 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
06/02/2005US20050116627 Electrochromic salts, solutions, and devices
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005CA2546817A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005CA2546096A1 4-substituted imidazoles
06/02/2005CA2546093A1 5-substituted imidazoles
06/02/2005CA2545711A1 Urea derivatives as kinase modulators
06/02/2005CA2545484A1 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin
06/02/2005CA2545196A1 Pyrazolopyrimidines
06/01/2005EP1536496A1 Organic light emitting device
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1534714A2 Liquid crystal display and colour filter with improved transparency for green light
06/01/2005EP1534713A1 Alkyl-substituted pyrazolopyrimidines
06/01/2005EP1534712A2 Pyrazolo[1,5-a]pyrimidine compounds as cyclin dependent kinase inhibitors
06/01/2005EP1534711A1 Phenyl-substituted pyrazolopyrimidines
06/01/2005EP1534710A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/01/2005EP1534709A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
06/01/2005EP1534389A2 Pyrazolopyrimidines as kinase inhibitors
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1534285A2 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
06/01/2005EP1335730B1 Use of pde5 inhibitors for the treatment of premature ejaculation
06/01/2005EP1296985B1 Heteropolycyclic inhibitors
06/01/2005EP1003744B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
06/01/2005EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
06/01/2005EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
06/01/2005CN1203837C Dye composition containing cationic direct dye and pyraole (1, 5-alpha) pyradine as oxidative developing alkali and method of dyeing
05/2005
05/31/2005US6900316 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
05/31/2005US6900220 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
05/31/2005US6900217 Substituted 6,5-hetero-bicyclic derivatives
05/31/2005US6900215 Imidazo-pyrimidine derivatives as ligands for gaba receptors
05/31/2005US6900209 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition
05/31/2005US6900208 Antiinflammatory agents; osteoporosis; anticancer agents
05/31/2005US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/31/2005US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
05/31/2005US6900197 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
05/31/2005US6899992 Imaging, development lithography printing plates
05/26/2005WO2005047414A1 Allergen decomposer and antiallergenic feather
05/26/2005WO2005047290A2 Imidazo[1,2-a] pyrazin-8-ylamines as kinase inhibitors
05/26/2005WO2005047289A1 Pyrrolopyrimidine compounds useful in treatment of cancer
05/26/2005WO2005047288A1 Pyrazolopyrimidines as anti - hepatits c agents
05/26/2005WO2005047287A2 Bicyclic pyrazolone cytokine inhibitors
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 573